% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

  • myownhedgefund myownhedgefund Feb 4, 2013 8:16 PM Flag

    2013 options priced

    Sorry cant post the links.

    CC very well rewarded of course but note the split pricing of $2.74 and $5.00.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Don't see filing at

      Sentiment: Strong Buy

      • 3 Replies to wall_street_titan
      • FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
        Washington, D.C. 20549


        OMB Number: 3235-0287
        Estimated average burden
        hours per response... 0.5

        Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

        1. Name and Address of Reporting Person *

        CALHOUN CHRISTOPHER J 2. Issuer Name and Ticker or Trading Symbol

        CYTORI THERAPEUTICS, INC. [ CYTX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

        __ X __ Director _____ 10% Owner
        __ X __ Officer (give title below) _____ Other (specify below)
        Chief Executive Officer
        (Last) (First) (Middle)

        3020 CALLAN ROAD 3. Date of Earliest Transaction (MM/DD/YYYY)


        SAN DIEGO, CA 92121
        (City) (State) (Zip) 4. If Amendment, Date Original Filed (MM/DD/YYYY)

        6. Individual or Joint/Group Filing (Check Applicable Line)

        _ X _ Form filed by One Reporting Person
        ___ Form filed by More than One Reporting Person

        Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
        1.Title of Security
        (Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
        (Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
        (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
        (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
        Code V Amount (A) or (D) Price
        Restricted Stock (Common Stock) 1/31/2013 D 21105 (1) D $0 147270 D
        Common Stock 36850 I By 401(k) Plan

        Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
        1. Title of Derivate Security
        (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
        (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
        (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
        (Instr. 3 and 4) 8. Price of Derivative Security
        (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
        Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
        Employee Stock Option $2.74 1/31/2013 A 250000 2/28/2013 (2) 1/31/2023 Common Stock 250000 $0 1235000 D
        Employee Stock Option $5.00 1/31/2013 A 125000 2/28/2013 (2) 1/31/2023 Common Stock 125000 $0 1360000 D

        Explanation of Responses:
        ( 1) On January 31st, 2013 the Compensation Committee of the Board of Directors determined that 58% of the performance goals for the 2012 performance conditioned restricted stock grant were achieved, and that such percentage of shares granted will continue to time vest through January 10, 2014. The remaining portion of the 2012 performance grant shares (42%) are no longer qualified to continue vesting and have been cancelled. The disposition of these cancelled shares is reflected in Table I above.
        ( 2) The Employee Stock options vest 1/48th each month from date of grant.

        Reporting Owners

        Reporting Owner Name / Address Relationships
        Director 10% Owner Officer Other
        3020 CALLAN ROAD
        SAN DIEGO, CA 92121 X
        Chief Executive Officer


        Jonathan E. Soneff, By Power of Attorney For: Christopher J. Calhoun 2/4/2013
        ** Signature of Reporting Person Date

        Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
        * If the form is filed by more than one reporting person, see Instruction 4(b)(v).
        ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
        Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
        Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

      • See Fas' site

      • I found them there. Links on Fas' site

    • Calhoun:
      250,000 shares at $2.74
      125,000 shares at $5.00

      Hedrick, Saad and Shirahama also got theirs !!! (somewhat smaller amounts)

2.96-0.01(-0.34%)May 27 4:00 PMEDT